國立虎尾科技大學 |

ADAMTS13 = Biology and Disease /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	ADAMTS13/ edited by George M. Rodgers.
Reminder of title:	Biology and Disease /
other author:	Rodgers, George M.
Description:	X, 186 p. 33 illus., 24 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Proteomics. -
Online resource:	https://doi.org/10.1007/978-3-319-08717-7
ISBN:	9783319087177

ADAMTS13 = Biology and Disease /
ADAMTS13Biology and Disease /[electronic resource] :edited by George M. Rodgers. - 1st ed. 2015. - X, 186 p. 33 illus., 24 illus. in color.online resource.

1. A13: Structure and function -- 2. A13: The von Willebrand factor cleaving protease -- 3. A13: Angiogenesis and other biologic activities -- 4. A13: Assays -- 5. Inherited A13 deficiency (Upshaw-Schulman Syndrome) -- 6. Acquired A13 deficiency (TTP) -- 7. Related thrombotic microangiopathies -- 8. Future directions.

This comprehensive volume discusses the protease ADAMTS13, summarizing the current status of basic and clinical research. The nine authoritative chapters begin with a historical perspective followed by exploration of the biochemistry and structure-function relationships of ADAMTS13 as well as its normal function in hemostasis (cleavage of von Willebrand factor). Emerging research themes for ADAMTS13 are covered, including its potential role in angiogenesis and other aspects of cell biology. Additional topics include laboratory assays for ADAMTS13, inherited ADAMTS13 deficiency, and acquired ADAMTS13 deficiency. A chapter on related thrombotic microangiopathic (TMA) disorders examines the differences between TMAs associated with ADAMTS13 deficiency and those not associated with ADAMTS13 deficiency. A final chapter reviews the preliminary information on emerging aspects of ADAMTS13, such as the status of recombinant ADAMTS13 products and their potential utility. Comprehensive in its exploration of the ADAMTS13 protease in disease, ADAMTS13: Biology and Disease is a significant resource for clinical hematologists, transfusion medicine physicians, and researchers interested in hemostasis, vascular biology, biochemistry, and metalloproteases.

ISBN: 9783319087177

Standard No.: 10.1007/978-3-319-08717-7doiSubjects--Topical Terms:

581930
Proteomics.

LC Class. No.: QD431-431.7

Dewey Class. No.: 572.6

ADAMTS13 = Biology and Disease /
LDR:02934nam a22003975i 4500 001 966642
003 DE-He213
005 20200706065213.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319087177 $9 978-3-319-08717-7
024 7 $a 10.1007/978-3-319-08717-7 $2 doi
035 $a 978-3-319-08717-7
050 4 $a QD431-431.7
072 7 $a PSBC $2 bicssc
072 7 $a SCI007000 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 572.6 $2 23
245 1 0 $a ADAMTS13 $h [electronic resource] : $b Biology and Disease / $c edited by George M. Rodgers.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a X, 186 p. 33 illus., 24 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. A13: Structure and function -- 2. A13: The von Willebrand factor cleaving protease -- 3. A13: Angiogenesis and other biologic activities -- 4. A13: Assays -- 5. Inherited A13 deficiency (Upshaw-Schulman Syndrome) -- 6. Acquired A13 deficiency (TTP) -- 7. Related thrombotic microangiopathies -- 8. Future directions.
520 $a This comprehensive volume discusses the protease ADAMTS13, summarizing the current status of basic and clinical research. The nine authoritative chapters begin with a historical perspective followed by exploration of the biochemistry and structure-function relationships of ADAMTS13 as well as its normal function in hemostasis (cleavage of von Willebrand factor). Emerging research themes for ADAMTS13 are covered, including its potential role in angiogenesis and other aspects of cell biology. Additional topics include laboratory assays for ADAMTS13, inherited ADAMTS13 deficiency, and acquired ADAMTS13 deficiency. A chapter on related thrombotic microangiopathic (TMA) disorders examines the differences between TMAs associated with ADAMTS13 deficiency and those not associated with ADAMTS13 deficiency. A final chapter reviews the preliminary information on emerging aspects of ADAMTS13, such as the status of recombinant ADAMTS13 products and their potential utility. Comprehensive in its exploration of the ADAMTS13 protease in disease, ADAMTS13: Biology and Disease is a significant resource for clinical hematologists, transfusion medicine physicians, and researchers interested in hemostasis, vascular biology, biochemistry, and metalloproteases.
650 0 $a Proteomics. $3 581930
650 0 $a Hematology. $3 645254
650 0 $a Cell biology. $3 1253486
650 2 4 $a Cell Biology. $3 593889
700 1 $a Rodgers, George M. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1063580
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319087160
776 0 8 $i Printed edition: $z 9783319087184
776 0 8 $i Printed edition: $z 9783319347301
856 4 0 $u https://doi.org/10.1007/978-3-319-08717-7
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)